Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01516333 · ClinicalTrials.gov registry record · Phase 1
Replace Glycemic Load and Satiety Study
A Phase 1 study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT01516333: Completed Phase 1 study, sponsored by Pennington Biomedical Research Center.
NCT01516333 is a Phase 1 study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 26 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01516333, a Phase 1 study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
The study is to examine the effect of four diets differing in glycemic index and amount of carbohydrate on blood sugar and insulin and in hunger, satiety, and vigor.
Primary Outcome
Blood glucose demonstrates that diets of different glycemic load result in measurable differences in serum glucose and insulin.
Interventions
- OTHER High GL 107
- OTHER Medium GL 76
- OTHER Medium GL 68
- OTHER Low GL 48
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2007-02 |
| Est. Completion | 2007-06 |
| Phase | Phase 1 |
What the finished NCT01516333 record still lists
NCT01516333 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 4 interventions - of which High GL 107 is the first listed.
NCT01516333 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01516333 about?
NCT01516333 is a clinical study titled "Replace Glycemic Load and Satiety Study". The study is to examine the effect of four diets differing in glycemic index and amount of carbohydrate on blood sugar and insulin and in hunger, satiety, and vigor.
What is the current status of trial NCT01516333?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2007-02. Estimated completion is 2007-06.
What interventions are being tested in trial NCT01516333?
The interventions under investigation include: High GL 107 (OTHER), Medium GL 76 (OTHER), Medium GL 68 (OTHER), Low GL 48 (OTHER).
Who is sponsoring clinical trial NCT01516333?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01516333's enrollment target sits among peer trials
26 1482nd of 2000 higher than 506 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia